US$ 26.88
bpc-157 administration methods Sample of patents with BPC 157 utilization Oral vs Injectable BPC-157: Differences,
Description
A Promising Future Although Tesofensine is not yet FDA-approved for obesity, the data is strong, and its clinical use is growing in progressive, evidence-based clinics

A 31-gauge needle measures 0.26 millimeters

doi:10.1007/s40123-025-01119-w 7

If you were working with the 10mg vial, you were dealing with a pre-mixed solution at 2.5mg per 0.5ml
